Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-2051-2023Class II

Exactech Ergo Impactor Handle, Catalog #321-09-05

Exactech, Inc. / initiated 2023-06-05 / Open, Classified / root cause: manufacturing process

Exactech, Inc. began a recall of Exactech Ergo Impactor Handle, Catalog #321-09-05 on . FDA classified it as Class II and gives the reason as "The ball and spring housed within the locking mechanism of the handle can dislodge during disassembly or during impaction". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-2051-2023
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Exactech, Inc.
Product
Exactech Ergo Impactor Handle, Catalog #321-09-05.
Product code
HWA Impactor
Reason for recall
The ball and spring housed within the locking mechanism of the handle can dislodge during disassembly or during impaction.
Root cause tag
manufacturing process
FDA root cause
Process control
Action
The recalling firm issued the letters via email to their U.S. agents and OUS on 6/5/2023. The letter explained the reason for recall, risk to health, how to recognize that the device may fail or has failed, the actions being taken by the recalling firm, and the actions to be taken by the customer/user. Regarding the actions being taken by the recalling firm, the letter reported they have implemented a new revision of the impactor handle to eliminate the cause of this event. Upon receipt of the attached Recall Acknowledgement Form, the recalling firm will provide the consignee with new revision parts to replace the recalled devices the consignee has in their inventory. Additionally, the recalling firm updated the Equinoxe Shoulder Operative Techniques to include the statement "WARNING: Do not assemble or disassemble device in the surgical field." The letter contained the links to the two updated operative techniques. Actions to be taken by the customer/user included immediately cease distribution or use of the product and quarantine any of the devices in the consignee's inventory or their customer's inventory and return them back to the recalling firm. The consignee was to provide the recall information to their accounts who may have the product in their possession. The enclosed Recall Inventory Response Form was to be completed and returned to the recalling firm via email. The response form is for the consignee to report they have read and understand the instruction, checked their stock and quarantined inventory, as well as indicating the inventory they are returning, and that they have identified and notified their customers who were shipped or may have been shipped this product.
Quantity in commerce
784 devices
Distribution
Distribution was made to AR, CA, CO, FL, GA, HI, ID, IL, IN, KS, KY, LA, MD, ME, MN, NH, NV, NY, OH, OK, PA, SC, TN, TX, WI, as well as PR. There was no government/military distribution. Foreign distribution was made to Australia, France, and Japan.
Product codes and lots
Catalog #321-09-05 - Lot numbers: 147544002, 275151004, 275151005, 275151006, 314934001, 400107002, and 400798002; UDI-DI 10885862557674. Updated data - 01/31/2025: Additional Lot Numbers 401819005 401819007 401819008 404552002 405492002 405253003 406041001

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-2051-2023
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-2050-2023Class IIOngoingVoluntary: Firm initiated
Z-2051-2023Class IIOngoingVoluntary: Firm initiated